|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn162568951 |
003 |
OCoLC |
005 |
20231117014919.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
070806s1995 enka ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OPELS
|d OCLCQ
|d N$T
|d E7B
|d OCLCQ
|d OCLCF
|d UIU
|d OCLCQ
|d STF
|d D6H
|d LEAUB
|d OL$
|d VLY
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 173260591
|a 648307260
|a 1035706587
|a 1162208517
|
020 |
|
|
|a 9780080526690
|q (electronic bk.)
|
020 |
|
|
|a 0080526691
|q (electronic bk.)
|
020 |
|
|
|z 9780120133260
|
020 |
|
|
|z 0120133261
|
020 |
|
|
|a 1281036889
|
020 |
|
|
|a 9781281036889
|
020 |
|
|
|a 9786611036881
|
020 |
|
|
|a 6611036881
|
035 |
|
|
|a (OCoLC)162568951
|z (OCoLC)173260591
|z (OCoLC)648307260
|z (OCoLC)1035706587
|z (OCoLC)1162208517
|
050 |
|
4 |
|a RS91
|b .A38 1995
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1
|2 22
|
096 |
|
|
|a QV 38
|f ADV
|
245 |
0 |
0 |
|a Advances in drug research.
|n Volume 26 /
|c ed. by Bernard Testa-- and Urs A. Meyer--.
|
260 |
|
|
|a London ;
|a San Diego ;
|a New York :
|b Academic Press,
|c �1995.
|
300 |
|
|
|a 1 online resource (xi, 279 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in drug research,
|x 0065-2490 ;
|v v. 26
|
520 |
|
|
|a Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.
|
505 |
0 |
|
|a L.B. Kier and B. Testa, Complexity and Emergence in Drug Research. -- M.S. Tute, Drug Design: the Present and the Future. -- K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools. -- C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research. -- J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment. -- Subject Index. -- Cumulative Index of Authors. -- Cumulative Index of Titles.
|
504 |
|
|
|a Bibliographie en fin de chapitre et index.
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmacy.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmacology.
|2 fast
|0 (OCoLC)fst01060259
|
650 |
|
7 |
|a Pharmacy.
|2 fast
|0 (OCoLC)fst01060285
|
650 |
|
7 |
|a M�edicaments.
|2 fmesh
|
650 |
|
7 |
|a Conception m�edicament.
|2 fmesh
|
700 |
1 |
|
|a Testa, Bernard.
|
700 |
1 |
|
|a Meyer, Urs A.
|
776 |
0 |
8 |
|i Print version:
|t Advances in drug research. Volume 26.
|d London ; San Diego ; New York : Academic Press, �1995
|z 0120133261
|z 9780120133260
|w (OCoLC)33429835
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120133260
|z Texto completo
|